IX Biopharma (42C.SG) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Aug29

IX Biopharma released FY2025 Annual Earnings on August 29, 2025 (SGT) with actual revenue of SGD 7.767 M and EPS of SGD -0.0116

15:00

IX Biopharma released FY2025 9 Months Earnings on August 29 SGT, with actual revenue of SGD 5.74 M and EPS of SGD -0.0094

15:00

IX Biopharma released FY2025 Q3 earnings on August 29, 2025 (SGT) with actual revenue of SGD 2.027 M and EPS of SGD -0.0022

15:00

IX Biopharma released FY2025 Q4 earnings on August 29 (SGT), actual revenue SGD 2.027 M, actual EPS SGD -0.0022

15:00

Feb7

IX Biopharma released FY2025 Semi-Annual Earnings on February 7, 2025 (SGT) with actual revenue of 3.713 M SGD and EPS of -0.0072 SGD

15:00

IX Biopharma released FY2025 Q1 earnings on February 7, 2025 (SGT) with actual revenue of 1.857 M SGD and EPS of -0.0036 SGD

15:00

Schedules & Filings

Schedules

Filings

Aug29

Earning Release(CST)

FY2025 Q4 Earning Release (SGD) Revenue 2.027 M, Net Income -1.946 M, EPS -0.0022

Feb7

Earning Release(CST)

FY2025 Q2 Earning Release (SGD) Revenue 1.857 M, Net Income -3.125 M, EPS -0.0036

Aug23

Earning Release(CST)

FY2024 Q4 Earning Release (SGD) Revenue 1.644 M, Net Income -1.733 M, EPS -0.0022

View More

Stock List

Top Gainers

Top Decliners

Popular

Symbol

Price

%Chg

Change

View More